Results 261 to 270 of about 287,603 (362)

Metabolic abnormalities and reprogramming in cats with naturally occurring hypertrophic cardiomyopathy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1256-1270, April 2025.
Abstract Background and aims The heart is a metabolic organ rich in mitochondria. The failing heart reprograms to utilize different energy substrates, which increase its oxygen consumption. These adaptive changes contribute to increased oxidative stress.
Qinghong Li   +12 more
wiley   +1 more source

Glucocorticoid-induced hyperglycaemia in hospitalised adults: A matched cohort study (2013-2023). [PDF]

open access: yesDiabetes Obes Metab
Golubic R   +6 more
europepmc   +1 more source

Immune Checkpoint Inhibitors and Cardiovascular Adverse Events

open access: yesESC Heart Failure, Volume 12, Issue 4, Page 2404-2416, August 2025.
Abstract In the last years, we assisted to a tremendous increase in therapeutic options for the management of cancers, with immunotherapy at the forefront of this innovation. Immune checkpoint inhibitors (ICIs) have been developed to enhance the activity of the immune system against cancer cells (1) and the number of approvals for ICIs has rapidly ...
Maria Luisa De Perna   +4 more
wiley   +1 more source

Skeletal muscle and subcutaneous fat quantity as prognostic indicators in cardiac amyloidosis

open access: yesEuropean Journal of Heart Failure, EarlyView.
Aims Disease‐related changes in body composition are associated with worse outcomes in chronic heart failure. In cardiac amyloidosis (CA), the prognostic value of direct body composition measures is understudied. Methods and results We identified 160 consecutive patients with CA (transthyretin [ATTR] or light chain [AL]) diagnosed between 2001 and 2021
Joshua Longinow   +4 more
wiley   +1 more source

Prolonged glucocorticoid use and rheumatoid arthritis-associated cervical spine deformity. [PDF]

open access: yesClin Rheumatol
Lebouille-Veldman AB   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy